Journal of Clinical Medicine (Mar 2023)

Correction: Kohsaka et al. Risk–Benefit Balance of Renin–Angiotensin–Aldosterone Inhibitor Cessation in Heart Failure Patients with Hyperkalemia. <i>J. Clin. Med.</i> 2022, <i>11</i>, 5828

Shun Kohsaka,
Suguru Okami,
Naru Morita,
Toshitaka Yajima

Affiliations

Shun Kohsaka: Department of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan
Suguru Okami: Cardiovascular, Renal, and Metabolism, Medical Affairs, AstraZeneca K.K., Osaka 530-0011, Japan
Naru Morita: Cardiovascular, Renal, and Metabolism, Medical Affairs, AstraZeneca K.K., Osaka 530-0011, Japan
Toshitaka Yajima: Cardiovascular, Renal, and Metabolism, Medical Affairs, AstraZeneca K.K., Osaka 530-0011, Japan

DOI: https://doi.org/10.3390/jcm12072578
Journal volume & issue: Vol. 12, no. 7
p. 2578

Abstract

In the original publication [...]

n/a

Published in Journal of Clinical Medicine

ISSN: 2077-0383 (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine
Website: http://www.mdpi.com/journal/jcm

About the journal